Protalix BioTherapeutics (PLX) Stock Heads Up On FDA BLA Acceptancet

Zomedica ZOM Stock News

Protalix BioTherapeutics Inc (NYSEAMERICAN: PLX) is making a run for the top in the premarket hours this morning, and for good reason. The company announced that the FDA has accepted a Biologics License Application, or BLA. Here’s what’s going on: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! PLX Stock … Read more

Protalix BioTherapeutics (PLX) Stock: Climbing On Positive Data

Protalix BioTherapeutics Inc (NYSEAMERICAN: PLX) is having an incredibly strong start to the trading session this morning, and for good reason. The comapny announced positive preliminary clinical data, exciting investors who are sending the stock screaming for the top. Today, we’ll talk about: The data; what we’re seeing from PLX as a result; and what … Read more

Protalix BioTherapeutics (PLX) Stock: Flying On Expanded Partnership

Protalix BioTherapeutics Inc (NYSEAMERICAN: PLX) is flying early on in the trading session this morning after the company announced news surrounding an expanded partnership. The news came with a hefty upfront payment and promise of potential revenue ahead. Of course, that excited investors who are sending the stock screaming for the top. Today, we’ll talk … Read more

Protalix BioTherapeutics (PLX) Stock: Gaining On Fast Track Designation

Protalix BioTherapeutics, Inc. (NYSE: PLX) is having an incredibly strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced that a key treatment it is working on has been granted Fast Track Designation by the United States Food and Drug Administration. Today, we’ll talk about the designation, … Read more

Protalix Biotherapeutics (PLX) Stock: Gaining On Positive Data

Protalix Biotherapeutics Inc (NYSEAMERICAN: PLX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced overwhelmingly positive interim data from a key clinical trial. Today, we’ll talk about the data that was released, what we’re seeing from the stock as a result, and what we’ll be … Read more

Protalix BioTherapeutics (PLX) Stock: Gaining On Collaboration Agreement

Protalix BioTherapeutics, Inc. (NYSEMKT: PLX) is having an overwhelmingly strong start to the trading session in the pre-market this morning, and for good reason. The company announced that it has entered into a license and collaboration agreement, leading to excitement among investors and sending the stock toward the top. As is normally the case, our … Read more

Protalix BioTherapeutics (PLX) Stock: Gaining On FDA News

Portalix BioTherapeutics Rg (NYSEMKT: PLX) is having an incredibly strong morning in the pre-market trading hours, and for good reason. The company announced that the FDA has accepted a Supplemental New Drug Application. Of course, this led to excitement among investors who pushed the stock toward the sky. As is almost always the case, our … Read more

Protalix Biotherapeutics (PLX) Stock: Gaining Big Ahead Of Phase 2 Data Release

Protalix Biotherapeutics Rg (NYSEMKT: PLX) Protalix Biotherapeutics is having an incredibly strong day in the market today. After starting the day in the green, the stock quickly headed up further. Throughout the morning, we’ve seen movement in both directions, but strong gains seem to be here to stay – at least for now. Below, we’ll talk … Read more

Protalix BioTherapeutics (PLX) Stock: Gaining Big On Coming Presentations

Protalix BioTherapeutics Inc. (NYSEMKT: PLX) Protalix BioTherapeutics is having an overwhelmingly strong day in the market today. When the trading session opened for business, the stock was already trading slightly in the green. From there, we saw strong upward movement, quickly bringing the stock to impressive gains. Below, we’ll talk about what we’re seeing from … Read more